The 4 reports from 2 analysts offering long term price targets
for Deepak Nitrite Ltd. have an average target of 600.50. The consensus estimate
represents a downside of -41.25%
from the last price of 1022.20.
Deepak Nitrite (DEN) posted another strong performance in Q4FY20. Impact from COVID-19 led nationwide lockdown was counterbalanced by consistent margin profiles across business segments.
Dazzled by all but miraculous showing of DNL's barely pretentious performance products business in last few quarters, DNL's consolidated PBT surged by all but astonishing 377.6% in the first nine months of FY20 compared to that in the same period a year ago. Thanks to pinched supply of DASDA globally, DNL's performance products business EBIT leapfrogged nearly tenfold in the reported period, though sales advanced by a miserly 2x. Yet margins of performance products have moderated in last few quarters, declining to 54.1% in Q3 from 58.1% in Q1, with further...
Hurt by planned shutdown of the phenol for two weeks coupled with moderation in global phenol prices, DNL's phenolics business posted over 13% drop in revenues last quarter, while crack spreads continued its moderation not least due to slowdown in global economic growth and subdued activity in Indian real estate and automobile sectors. EBIT margin as a consequence slid to 5.6% in Q2 compared to 11.8% in the preceding...
Deepak Nitrite's (DEN) base business continued on its robust growth momentum in Q2FY20, particularly driven by the stellar performance of the Performance Products (PP) segment.
Deepak Nitrite (DEN) recorded impressive growth during the quarter with 127% y-o-y and 4% sequential increase in revenues to INR 1,051 crore, ahead of our estimates by 3%.
Propelled by higher off take of high margin products and firm overall realizations, revenues of Deepak's basic chemicals business rose by a satisfying 14.8%, in 9MFY19, a marked improvement from 7.3% reported last fiscal. Margins rose too - 15.9% Vs 13.9% but not without discernible fluctuations in margins over the last few quarters. Deepak's seemingly most potent fine & speciality chemicals business incredibly benefitted from higher volume growth - resulting from higher utilization and backward integration initiatives - in both domestic and overseas markets....
DNL holds a strong market position in India in several of its chosen niches within the chemical industry. DNL's inhouse R&D; has recently helped add successful new products to its line-up and a strong export...
Sluggish overall volume growth (5%) failed to scupper business growth for overall revenues surged by 19.4% in Q4 - markedly improved from 6.1% in Q1- and operating margin rose by some 30 bps. Striking increases in both interest (34.1%) and depreciation expenses (14.3%) scarcely put brakes on PBT - which rose by a stunning 46.5%. Yet post...
Deepak Nitrite (DEN) delivered 24% topline growth (9% above our expectations) led by optimal capacity utilisation in the basic chemicals business and normalisation of operations at its Roha unit (impa
Deepak Nitrite Ltd: Q3FY18 Result Update : We expect the basic chemicals business to continue showing steady growth on account of demand uptick and supply disruptions from China. The...
Deepak Nitrite Ltd. (DEN) is set to commence commercial operations of acetone-phenol at its 100% subsidiary Deepak Phenolics Ltd. post successful funding of nearly INR 1,250 crore over the...
as compared to the same quarter previous year. The increased profitability is due to the healthy demand in export markets in the Fine & Specialty Chemicals segment and improved realizations in the Basic Chemicals Segment. Recommendation The increased volatility in global prices of major chemicals and improved demand traction due to difficulties in sourcing from China would open up opportunities domestically. Government's focus on eliminating the infrastructure gaps with DNL's focus towards R&D; and developing new variants would benefit the company. Phenol and Acetone's capex will provide DNL a...
Vitality in DNL's basic chemicals business (gross revenues up 12.6%; EBIT up 38.3%) and recognition of insurance claim of Rs 18.33 crs ($2.8m) on account of loss of profits due to business interruption from the fire at its Roha facility last fiscal, failed to buttress revenues (net revenues up a measly 6.1%) last quarter. Delays in getting clearance from local authorities for select high value products in the FSC segment coupled with short supply of some products precluded production of some high margin products. As a result, FSC's gross revenues (excluding insurance claim sum) nosedived...
Misfortune hit DNL's business hard last quarter for the shutdown of its DASDA plant in Hyderabad due to torrential rains was soon followed by a fire in one of the distillation columns of its manufacturing facility at Roha (Maharashtra). Wherefore its income from operations saw the sharpest fall in at least seven quarters and absolute profits showed the lowest reading in thirteen quarters. DASDA plant shutdown (temporary though) accentuated the torpidity in OBA demand for revenues of performance products (erstwhile fluorescent whitening agent) nosedived by a depressing 28.1%....
segments namely basic chemicals, fine and specialty chemicals five manufacturing facilities located at Nandesari, Dahej (Gujarat), Roha, Taloja (Maharashtra) and Hyderabad (Telangana)....
